These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19745081)

  • 1. Therapeutic use of tea derivatives: all that glitters is not gold.
    Mancuso C; Barone E
    Blood; 2009 Sep; 114(11):2359-60. PubMed ID: 19745081
    [No Abstract]   [Full Text] [Related]  

  • 2. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors.
    Golden EB; Lam PY; Kardosh A; Gaffney KJ; Cadenas E; Louie SG; Petasis NA; Chen TC; Schönthal AH
    Blood; 2009 Jun; 113(23):5927-37. PubMed ID: 19190249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural polyphenols antagonize the antimyeloma activity of proteasome inhibitor bortezomib by direct chemical interaction.
    Kim TY; Park J; Oh B; Min HJ; Jeong TS; Lee JH; Suh C; Cheong JW; Kim HJ; Yoon SS; Park SB; Lee DS;
    Br J Haematol; 2009 Aug; 146(3):270-81. PubMed ID: 19500098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF potentiates anticancer activity of bortezomib (Velcade) through reduced expression of proteasome subunits and dysregulation of unfolded protein response.
    Nowis D; McConnell EJ; Dierlam L; Palamarchuk A; Lass A; Wójcik C
    Int J Cancer; 2007 Jul; 121(2):431-41. PubMed ID: 17373661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovation in myeloma treatments PARP excellence!
    Fonseca R
    Blood; 2011 Dec; 118(24):6234-5. PubMed ID: 22161848
    [No Abstract]   [Full Text] [Related]  

  • 6. From orbital hybridization to chemotherapeutics neutralization.
    Ghosh N; Emadi A
    Blood; 2009 Jun; 113(24):6262. PubMed ID: 19520822
    [No Abstract]   [Full Text] [Related]  

  • 7. Dietary Flavonoids with Catechol Moiety Inhibit Anticancer Action of Bortezomib: What about the other Boronic Acid-based Drugs?
    Sak K
    Curr Cancer Drug Targets; 2022; 22(9):741-748. PubMed ID: 35578889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
    Altmann A; Markert A; Askoxylakis V; Schöning T; Jesenofsky R; Eisenhut M; Haberkorn U
    J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib.
    Piva R; Ruggeri B; Williams M; Costa G; Tamagno I; Ferrero D; Giai V; Coscia M; Peola S; Massaia M; Pezzoni G; Allievi C; Pescalli N; Cassin M; di Giovine S; Nicoli P; de Feudis P; Strepponi I; Roato I; Ferracini R; Bussolati B; Camussi G; Jones-Bolin S; Hunter K; Zhao H; Neri A; Palumbo A; Berkers C; Ovaa H; Bernareggi A; Inghirami G
    Blood; 2008 Mar; 111(5):2765-75. PubMed ID: 18057228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib.
    Liu FT; Agrawal SG; Movasaghi Z; Wyatt PB; Rehman IU; Gribben JG; Newland AC; Jia L
    Blood; 2008 Nov; 112(9):3835-46. PubMed ID: 18633129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of biochemical and biological effects of ML858 (salinosporamide A) and bortezomib.
    Williamson MJ; Blank JL; Bruzzese FJ; Cao Y; Daniels JS; Dick LR; Labutti J; Mazzola AM; Patil AD; Reimer CL; Solomon MS; Stirling M; Tian Y; Tsu CA; Weatherhead GS; Zhang JX; Rolfe M
    Mol Cancer Ther; 2006 Dec; 5(12):3052-61. PubMed ID: 17172407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on Perrone et al.: 'vitamin C: not for breakfast anymore...if you have myeloma'.
    Harvey RD; Nettles J; Wang B; Sun SY; Lonial S
    Leukemia; 2009 Nov; 23(11):1939-40. PubMed ID: 19904281
    [No Abstract]   [Full Text] [Related]  

  • 13. Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma.
    Bonvini P; Zorzi E; Basso G; Rosolen A
    Leukemia; 2007 Apr; 21(4):838-42. PubMed ID: 17268529
    [No Abstract]   [Full Text] [Related]  

  • 14. Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells.
    Fribley A; Zeng Q; Wang CY
    Mol Cell Biol; 2004 Nov; 24(22):9695-704. PubMed ID: 15509775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the green tea polyphenols catechin-3-gallate (CG) and epicatechin-3-gallate (ECG) as proteasome inhibitors.
    Wan SB; Chen D; Dou QP; Chan TH
    Bioorg Med Chem; 2004 Jul; 12(13):3521-7. PubMed ID: 15186836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fold up or perish: unfolded protein response and chemotherapy.
    Strasser A; Puthalakath H
    Cell Death Differ; 2008 Feb; 15(2):223-5. PubMed ID: 18049478
    [No Abstract]   [Full Text] [Related]  

  • 17. High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma.
    Stessman HA; Lulla A; Xia T; Mitra A; Harding T; Mansoor A; Myers CL; Van Ness BG; Dolloff NG
    Leukemia; 2014 Nov; 28(11):2263-7. PubMed ID: 25005244
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity.
    Mimnaugh EG; Xu W; Vos M; Yuan X; Isaacs JS; Bisht KS; Gius D; Neckers L
    Mol Cancer Ther; 2004 May; 3(5):551-66. PubMed ID: 15141013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis.
    Kraus M; Malenke E; Gogel J; Müller H; Rückrich T; Overkleeft H; Ovaa H; Koscielniak E; Hartmann JT; Driessen C
    Mol Cancer Ther; 2008 Jul; 7(7):1940-8. PubMed ID: 18645004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel proteasome inhibitors to overcome bortezomib resistance.
    Ruschak AM; Slassi M; Kay LE; Schimmer AD
    J Natl Cancer Inst; 2011 Jul; 103(13):1007-17. PubMed ID: 21606441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.